Innate Pharma Reports Full Year 2025 Financial Results and Business Update

Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) ("Innate" or the "Company") today reported its business update and ...

Inside information: Bioretec Ltd's Board of Directors resolved on a rights issue of up to ...

The Board of Directors of Bioretec Ltd ("Bioretec" or the "Company") has today 27 March 2026, based on the authorisation of the Extraordinary General Meeting of the Company held on 27 March 2026, ...